We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.79B
AUM Growth
+$28.8M
Cap. Flow
-$185M
Cap. Flow %
-6.63%
Top 10 Hldgs %
33.01%
Holding
105
New
22
Increased
19
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$27.9M
2
A icon
Agilent Technologies
A
+$26.2M
3
ELV icon
Elevance Health
ELV
+$21M
4
CRL icon
Charles River Laboratories
CRL
+$15.9M
5
DXCM icon
DexCom
DXCM
+$14.9M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$83.8M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$75.6M
3
AXSM icon
Axsome Therapeutics
AXSM
+$33.9M
4
VEEV icon
Veeva Systems
VEEV
+$33.4M
5
NVRO
NEVRO CORP.
NVRO
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 81.16%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
51
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$19.6M 0.7%
917,557
+661,273
+258% +$14.1M
ACLX
52
DELISTED
Arcellx
ACLX
$19.1M 0.68%
+616,515
New +$14.1M
UHS icon
53
Universal Health Services
UHS
$10.4B
$17.5M 0.63%
+124,421
New +$14.7M
APLS
54
DELISTED
Apellis Pharmaceuticals
APLS
$16.5M 0.59%
318,422
+196,542
+161% +$10.4M
ABBV icon
55
CALL
AbbVie
ABBV
$435B
$16.2M 0.58%
+100,000
New +$15.3M
ICLR icon
56
Icon
ICLR
$12.6B
$15.9M 0.57%
81,725
-53,015
-39% -$10.5M
CRL icon
57
Charles River Laboratories
CRL
$12.6B
$15.9M 0.57%
+72,820
New +$15.9M
DXCM icon
58
DexCom
DXCM
$31.2B
$15.3M 0.55%
+135,465
New +$14.9M
EDIT icon
59
Editas Medicine
EDIT
$422M
$13M 0.47%
1,466,732
+187,678
+15% +$2.06M
THC icon
60
Tenet Healthcare
THC
$21.1B
$12.4M 0.44%
254,525
-290,058
-53% -$13.4M
LUNG icon
61
Pulmonx
LUNG
$83.6M
$12.3M 0.44%
1,455,770
+1,256,067
+629% +$11.9M
OSH
62
DELISTED
Oak Street Health, Inc.
OSH
$12.2M 0.44%
565,239
-157,605
-22% -$3.3M
GBIO
63
DELISTED
Generation Bio
GBIO
$11.4M 0.41%
290,319
-11,052
-4% -$580K
THC icon
64
CALL
Tenet Healthcare
THC
$21.1B
$11M 0.39%
+225,900
New +$10.4M
CELC icon
65
Celcuity
CELC
$4.53B
$9.98M 0.36%
712,111
+571,685
+407% +$5.85M
EPIX
66
DELISTED
ESSA Pharma
EPIX
$9.69M 0.35%
3,844,332
+2,366,080
+160% +$6.79M
PRTA icon
67
CALL
Prothena Corp
PRTA
$444M
$9.18M 0.33%
152,300
+71,800
+89% +$4.2M
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
$7.07M 0.25%
4,843,510
-4,477,074
-48% -$7.25M
PRAX icon
69
Praxis Precision Medicines
PRAX
$8.9B
$6.61M 0.24%
185,164
-45,404
-20% -$1.42M
BPMC
70
DELISTED
Blueprint Medicines
BPMC
$5.71M 0.2%
130,366
– –
VERV
71
DELISTED
Verve Therapeutics
VERV
$4.2M 0.15%
217,302
-951,506
-81% -$25.2M
CMPS
72
Compass Pathways
CMPS
$1.83B
$4.09M 0.15%
509,625
+111,914
+28% +$1.12M
LH icon
73
Labcorp
LH
$25.4B
$3.19M 0.11%
+15,785
New +$3.09M
PMVP icon
74
PMV Pharmaceuticals
PMVP
$62.4M
$2.9M 0.1%
333,716
-521,448
-61% -$5.56M
HOWL icon
75
Werewolf Therapeutics
HOWL
$19.5M
$2.65M 0.09%
1,293,293
-1,522,361
-54% -$3.98M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

PFM Health Sciences's Q4 2022 Portfolio in Review

As of Q4 2022, PFM Health Sciences held 105 positions worth $2.79B, up 1% from $2.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences withdrew a net $185M in Q4 2022, closing 16 positions and reducing 24 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $83.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 89% a quarter earlier, followed by Financials.

Against the trend, PFM Health Sciences opened a new position in Intuitive Surgical worth $30.4M.

  • PFM Health Sciences's largest Q4 2022 buy was Intuitive Surgical: 114,450 shares worth $30.4M.
  • PFM Health Sciences added most to Elevance Health in Q4 2022, an estimated $21M increase.
  • PFM Health Sciences's biggest Q4 2022 reduction was BioMarin Pharmaceuticals, cutting an estimated $75.6M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q4 2022, selling an estimated $83.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $2.79B portfolio in Q4 2022.
  • PFM Health Sciences opened 22 new positions and closed 16 in Q4 2022.
  • PFM Health Sciences's portfolio value rose 1% quarter-over-quarter to $2.79B.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.